Arno de Wilde
InvestorInvestor at EQT Life Sciences
Amsterdam, Netherlands
Writes $11M – $65M checks · typically $25M
Find your path to Arno
474 people in our graph share verified history with Arno — schools, employers, funds. One of them is your warm intro.
René KuijtenunlockedArno: together at EQT Group (2019–2026)
×5Arno: together at EQT Group
×2Arno: together at EQT Life Sciences
×3Arno: together at Vrije Universiteit Amsterdam (VU Amsterdam)
About
Arno de Wilde is a Managing Director at EQT Life Sciences and co-founder of its neuroscience fund, which manages €273 million in assets. He holds an MD and PhD in neurology from Amsterdam UMC, where he completed six years of clinical practice, and earned an MBA from INSEAD. De Wilde serves as a director on the boards of Aerska, Atalanta Therapeutics, and VectorY Therapeutics, and has published over 20 manuscripts and a book chapter on clinical trial design.
Experience
- EQT GroupManaging Directorcurrent2025 — presentАмстердам
- EQT GroupDirector2023 — 2024Amsterdam, North Holland, Netherlands
- EQT GroupVice President2022Амстердам
- EQT GroupAssociate2020 — 2022Амстердам
- EQT GroupAnalyst2019 — 2020Амстердам
- Amsterdam UMCMember of Societal Advisory Boardcurrent2024 — presentAmsterdam, North Holland, Netherlands
- AerskaBoard Directorcurrent2026 — present
- Atalanta TherapeuticsBoard Directorcurrent2024 — presentBoston, Massachusetts, United States
- VectorYBoard Directorcurrent2023 — presentAmsterdam, the Netherlands
- Nederlandse Vereniging van Participatiemaatschappijen (NVP)Member of VC Committeecurrent2023 — presentAmsterdam, North Holland, Netherlands
- Health~HollandMember of Program Committeecurrent2024 — presentThe Hague, South Holland, Netherlands
- Upgrade MedicalAdvisorcurrent2025 — presentUtrecht, Netherlands
- Bio-Neuroscience ConferenceMember of Advisory Boardcurrent2025 — present
- AstronauTxBoard Observer2023 — 2026London, England
- Asceneuron SABoard Observer2024 — 2025Lausanne, Vaud, Switzerland
- Nobi Smart LampsBoard Observer2022 — 2024Antwerp, Belgium
- QurAlisBoard Observer2022 — 2024Boston, Massachusetts, United States
- Amsterdam UMCPhysician-scientist (Neurology)2014 — 2020Amsterdam, North Holland, Netherlands
- UMC UtrechtPhysician-scientist (Neurology)2013 — 2014Utrecht, Utrecht, Netherlands
- UMC UtrechtGraduate Researcher (Neurology)2010 — 2013Utrecht, Netherlands
Skills & more
Portfolio Management4Investment Strategies1Deal Sourcing2Venture CapitalBoard of Directors
Languages Dutch · English
From Arno's professional profile.
Colleagues at EQT Life Sciences
Alex Darden
Partner and Head of EQT Infrastructure Advisory Team Americas & President of EQT Partners Inc at EQT Ventures
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Chris Stone
Investor at EPIC VENTURES
Christina Drews
Chief Operating Officer at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Network8
Anne Portwich
Partner at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Managing Director at EQT Life Sciences
Clemens van Blitterswijk
Venture Partner at EQT Life Sciences
Drew Burdon
Investor at LSP (Life Sciences Partners)
Fouad Azzam
Partner at EQT Life Sciences
Geraldine O'Keeffe
Partner at EQT Life Sciences
Investors connected to Arno in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Arno de Wilde?
- Arno de Wilde is a Managing Director at EQT Life Sciences and co-founder of its neuroscience fund, which manages €273 million in assets. He holds an MD and PhD in neurology from Amsterdam UMC, where he completed six years of clinical practice, and earned an MBA from INSEAD. De Wilde serves as a director on the boards of Aerska, Atalanta Therapeutics, and VectorY Therapeutics, and has published over 20 manuscripts and a book chapter on clinical trial design.
- Where does Arno de Wilde work?
- Arno de Wilde is Investor at EQT Life Sciences.
- What check size does Arno de Wilde write?
- Arno de Wilde typically writes checks of $11M – $65M.
- Where did Arno de Wilde go to school?
- Arno de Wilde studied at INSEAD (Executive Master of Business Administration - M.B.A.); Vrije Universiteit Amsterdam (VU Amsterdam) (Doctor of Philosophy - Ph.D.); Utrecht University (Bachelor’s and Master’s in Medicine - M.D.).
Same school
Also attended INSEAD1,154
Alexandre ProtCo-founder & CEO of QontoSteve AnaviCo-founder & President of QontoPatrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index Ventures
.jpg)
+ 1,148 more
Also attended Vrije Universiteit Amsterdam (VU Amsterdam)196
Brendan Bulik-SullivanInvestor at GV (Google Ventures)Johann FriederichAssociate at Notion CapitalTies KlinkhamerJunior Associate at Keen Venture PartnersAlex PortoInvestor at Riverwood CapitalMercedes TuinPartner at Heran PartnersProf. Dr. Jan Peter BalkenendeVoorzitter at Noaber
+ 190 more
Shared employers
Also worked at Aerska2
Also worked at Nederlandse Vereniging van Participatiemaatschappijen (NVP)9
René KuijtenInvestor at LSP (Life Sciences Partners)René SavelsbergCo-Founder & Partner at SET VenturesAnne PortwichPartner at EQT Life SciencesEwout PrinsManaging Partner at Holland CapitalMichael LucassenManaging Partner at TIIN CapitalRene KuijtenHead of EQT Life Sciences at EQT Life Sciences
+ 3 more
